IL17A and chronic obstructive pulmonary disease: We then tested the associations between this IL-17 signature and clinical features in 2 independent COPD studies that collected rich phenotypic data (GLUCOLD, n = 79, and SPIROMICS, n = 47; study design in Figure 1).